Most Cited Papers In Last Two Years

Amyloid-β-targeted therapies for Alzheimer's disease: currently and in the future

Can alpha-synuclein be both the cause and a consequence of Parkinson's disease?

Benefits of physical exercise on Alzheimer's disease: an epigenetic view

The role of domain alterations in F1Fo-ATPase dysfunction associated to neurodegenerative diseases

Aging and Parkinson's disease: a complex interplay of vulnerable neurons, the immune system and the blood-brain barrier

Pathogen infection in Alzheimer's disease: pathophysiology and therapeutic strategies

Circadian rhythm in neurodegenerative disease: the role of RNA modifications and potential application of RNA-based therapeutics

Sleep, glymphatic system, and Parkinson's disease

Potential roles of telomeres and telomerase in neurodegenerative diseases

Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer's disease

Development of small molecules for disrupting pathological amyloid aggregation in neurodegenerative diseases

Cannabinoid modulations of pain- and stress-related circuits

Research progress on the role of PGC1α in mitochondrial dysfunction associated with Alzheimer's disease

Identification of PLA2G6 variants in a Chinese patient with Parkinson's disease

A new Perspective on Parkinson's disease: exploring the involvement of intestine and vagus lysates in α-synucleinopathy propagation

The role of N6-methyladenosine modification in neurodegenerative diseases

Neural mechanisms underlying upright bipedal gait: role of cortico-brainstem-spinal pathways involved in posture-gait control

Re-energising the brain: glucose metabolism, Tau protein and memory in ageing and dementia